Panelists discuss screening recommendations and guidelines, including considerations for screening those patients with a smoking history.
Panelists discuss screening recommendations and guidelines, including considerations for screening those patients with a smoking history. They also discuss screening’s role in reducing mortality rates.
Dr Sugarbaker says the most recent recommendations from CMS are built on previous consensus studies which determine which groups of patients should receive annual screenings, and how often suspicious screenings should be followed up. When a nodule is found, depending on the size, surgery may be recommended.
Dr Corey says that in comparison to mammograms or colonoscopies, the impact and awareness of the National Lung Screening Trial (NLST) is not as well known. He suggests that guidelines should be more concrete, especially in regards to the regulation of patient follow-up.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Current and Emerging Options for Uncommon EGFR- and Exon 20 Insertion–Mutated NSCLC
September 8th 2025Uncommon EGFR mutations in non–small cell lung cancer (NSCLC) remain challenging to treat, but new tyrosine kinase inhibitors, bispecific antibodies, and a proposed “PACCage insert” framework provide opportunities to advance precision therapy.
Read More